MENU
+Compare
BNTX
Stock ticker: NASDAQ
AS OF
Oct 23, 04:59 PM (EDT)
Price
$104.74
Change
-$1.49 (-1.40%)
Capitalization
25.54B

BNTX BioNTech SE American Depositary Share Forecast, Technical & Fundamental Analysis

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid... Show more

BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BNTX with price predictions
Oct 22, 2025

BNTX in upward trend: 10-day moving average moved above 50-day moving average on October 15, 2025

The 10-day moving average for BNTX crossed bullishly above the 50-day moving average on October 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BNTX just turned positive on September 24, 2025. Looking at past instances where BNTX's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

BNTX moved above its 50-day moving average on October 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BNTX advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 154 cases where BNTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where BNTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on October 22, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BNTX as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for BNTX moved below the 200-day moving average on September 18, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BNTX broke above its upper Bollinger Band on October 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BNTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.173) is normal, around the industry mean (23.456). P/E Ratio (161.759) is within average values for comparable stocks, (54.478). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.160). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (7.553) is also within normal values, averaging (350.201).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BNTX is expected to report earnings to fall 36.25% to -101 cents per share on November 03

BioNTech SE American Depositary Share BNTX Stock Earnings Reports
Q3'25
Est.
$-1.02
Q2'25
Missed
by $0.19
Q1'25
Beat
by $0.27
Q4'24
Beat
by $0.60
Q3'24
Beat
by $2.36
The last earnings report on August 04 showed earnings per share of -160 cents, missing the estimate of -140 cents. With 719.21K shares outstanding, the current market capitalization sits at 25.54B.
A.I.Advisor
published Dividends

BNTX paid dividends on June 17, 2022

BioNTech SE American Depositary Share BNTX Stock Dividends
А dividend of $4.22 per share was paid with a record date of June 17, 2022, and an ex-dividend date of June 02, 2022. Read more...
A.I. Advisor
published General Information

General Information

a company, which focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
An der Goldgrube 12
Phone
+49 613190840
Employees
6133
Web
https://www.biontech.de
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DIVD36.88-0.03
-0.08%
Altrius Global Dividend ETF
GBAB15.50-0.04
-0.26%
Guggenheim Taxable Municipal
AQLT27.47-0.15
-0.55%
iShares MSCI Global Quality Factor ETF
GDV26.82-0.16
-0.59%
Gabelli Dividend & Income Trust (The)
RZG54.49-0.66
-1.20%
Invesco S&P SmallCap 600® Pure Gr ETF

BNTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-0.62%
MRNA - BNTX
55%
Loosely correlated
-2.33%
SMMT - BNTX
49%
Loosely correlated
+2.24%
KYMR - BNTX
48%
Loosely correlated
-4.32%
TIL - BNTX
46%
Loosely correlated
-2.58%
NVAX - BNTX
43%
Loosely correlated
-1.51%
More